New CRISPR/Cas9 technique corrects cystic fibrosis in cultured human stem cells

Researchers corrected mutations that cause cystic fibrosis in cultured human stem cells. They used a technique called prime editing to replace the 'faulty' piece of DNA with a healthy piece. The study shows that prime editing is safer than the conventional CRISPR/Cas9 technique.

from Top Health News -- ScienceDaily https://ift.tt/3CAqHmC